Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on R 5 Methyl 1 Aminoindan. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105154513A analysis reveals dynamic kinetic resolution for high-purity chiral intermediates. Achieve substantial cost reduction and supply chain reliability.
Patent CN105063163A reveals enzyme-catalyzed DKR for high-purity chiral intermediates. Offers cost reduction and scalable manufacturing for pharmaceutical supply chains.